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CARDIOVASCULAR LABILITY AS A POTENTIAL NEW PREDICTOR OF POST-OPERATIVE 
PATIENT PROGNOSIS IN THE INTENSIVE CARE UNIT 
Dhar, Deepali. Dai, Feng. Qadri, Saeeda. Acunta, Michael. Akhtar, Shamsuddin. Luczycki, 
Stephen. Silverman, David G. Department of Anesthesiology, Yale University, School of 
Medicine, New Haven, CT. 
Measuring individual patient outcomes in the intensive care unit (ICU) has been 
a difficult task at best. Multiple ICU scoring systems have been developed which are 
best used for assessing overall ICU performance. Recently the APGAR score, a simple 
metric based on worst cardiovascular parameters in operating r6 m, has been designed 
to determine morbidity and mortality in post-surgical ICU patients. C diovascular 
instability is very likely an important key to assessing and predicting poor outcomes. 
Beat-to-beat variability and blood pressure variability have been well characterized. 
The hypothesis for this study was that cardiovascular instability, as measured by 
lability in heart rate and blood pressure during the ICU stay, yields information that is 
different than the current ICU and APGAR scoring systems. This study captured ICU 
data on 10 post-operative patients at 5 minute intervals. Fluctuations over ICU stay in 
blood pressure and heart rate were measured as range, interquartile range, and 
coefficient of variation. These measures were analyzed to determine if they correlated 
with ICU and APGAR scores. Our results show that range, interquartile range, and 
coefficient of variation for heart rate, arterial systolic blood pressure, and diastolic 
blood pressure do not correlate with the scores and so provide different information 
that may better reflect a patient's instability and thus outcomes. From this work, we 
hope to develop more studies especially focused on morbidity and mortality outcomes. 
TABLE OF CONTENTS 
1. Introduction ................................................................................................. 1 
a. The role of assessment of the Intensive care patients ................. 1 
b. Severity of Illness scores: general concepts .................................. 4 
c. Severity of Illness scores: specifics .............................................. 10 
d. Comparison of Severity of Illness Scores ..................................... 12 
e. APGAR Score ................................................................................... 14 
f. Cardiovascular stability: better marker of prognosis? .............. 18 
g. Goals of our study .......................................................................... 23 
2. Statement of Purpose ................................................................................ 25 
3. Methods ...................................................................................................... 25 
4. Results ......................................................................................................... 27 
5. Discussion .................................................................................................. 31 
6. Appendix ................................................................................................... 36 
7. References ................................................................................................ 44 




I.	  The	  role	  of	  assessment	  of	  Intensive	  Care	  Unit	  Patients	  
The	  intensive	  care	  unit	  	  (ICU)	  houses	  the	  sickest	  patients	  in	  the	  hospital,	  
however	  these	  patients	  are	  not	  otherwise	  uniform	  or	  alike.	  No	  specific	  guidelines	  or	  
criteria	  exist	  that	  dictate	  which	  patients	  get	  admitted	  to	  the	  ICU	  –	  there	  is	  no	  
standardization	  in	  the	  type	  of	  disease/pathology,	  organ(s)	  involved,	  extent	  of	  
progression	  of	  disease,	  hemodynamic	  instability,	  length	  of	  illness	  (chronic	  or	  acute),	  age,	  
or	  really	  any	  other	  factor.	  	  Patients	  may	  have	  anything	  from	  myocardial	  infarction	  to	  
infection	  to	  renal	  failure.	  	  As	  such,	  ICU	  patients	  have	  a	  wide	  variety	  of	  
morbidities/diagnoses	  and	  capacity	  for	  recovery,	  and	  as	  a	  result	  have	  a	  wide	  range	  of	  
outcomes	  including	  prognosis,	  length	  of	  stay,	  and	  morbidity.	  
The	  ability	  to	  assess	  the	  severity	  of	  illness,	  prognosis	  of	  patients	  and	  outcomes	  in	  
the	  intensive	  care	  unit	  can	  be	  helpful	  for	  multiple	  reasons.	  (1)	  These	  reasons	  are	  not	  
limited	  to	  but	  include	  	  
	   1.	  Improving	  decision	  making	  for	  clinical	  management	  especially	  with	  respect	  to	  
therapeutic	  intervention:	  The	  ability	  to	  assess	  the	  severity	  of	  illness	  and	  prognosis	  of	  
the	  patient	  may	  help	  in	  determining	  the	  suitability	  of	  a	  patient	  to	  try	  novel	  therapies.	  
This	  is	  currently	  done	  for	  trials	  of	  potential	  therapies	  for	  sepsis	  and	  ARDS.	  	  rhAPC	  is	  
given	  in	  the	  case	  of	  sepsis	  for	  patients	  with	  a	  calculated	  APACHE	  score	  above	  a	  certain	  
threshold	  based	  on	  the	  PROWESS	  trial.	  (2)Interestingly,	  in	  these	  models,	  patients	  are	  
assigned	  either	  0	  or	  1	  (to	  receive	  an	  intervention	  or	  not)	  but	  the	  model	  predicts	  a	  risk	  
in	  the	  range	  of	  0-­‐1.	  Therefore,	  it	  may	  not	  be	  perfect	  for	  each	  individual	  patient	  
especially	  since	  these	  models	  do	  not	  factor	  in	  how	  strong	  a	  patient’s	  response	  to	  the	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therapy	  will	  be.	  Nevertheless,	  it	  does	  provide	  a	  cut-­‐off	  in	  helping	  to	  decide	  whether	  to	  
provide	  a	  certain	  intervention,	  especially	  if	  that	  intervention	  is	  very	  costly	  (see	  #2).	  	  
2.	  Optimizing	  resource	  allocation:	  This	  is	  linked	  to	  #1	  but	  expands	  well	  beyond	  it.	  
Evaluating	  and	  understanding	  an	  ICU’s	  resource	  allocation	  requires	  a	  more	  long-­‐term	  
evaluation	  of	  a	  specific	  ICU’s	  performance.	  	  	  Such	  an	  evaluation	  with	  severity	  scores	  
could	  be	  used	  to	  triage	  patients	  with	  lower	  scores	  to	  less	  expensive	  inpatient	  settings.	  
The	  Therapeutic	  Intervention	  Scoring	  System	  (TISS),	  for	  example,	  a	  severity	  of	  illness	  
score,	  reports	  workload	  and	  costs	  to	  evaluate	  and	  measure	  nursing	  workload.	  This	  is	  
well	  correlated	  to	  APACHE	  III	  and	  IV.	  (3-­‐6)	  
Knowing	  certain	  factors	  can	  help	  optimize	  resource	  allocation.	  	  These	  include	  
determining	  which	  patients	  are	  sicker	  via	  markers	  like	  mortality,	  ICU	  length	  of	  stay,	  and	  
readmission	  rate.	  (1)	  
While	  it	  would	  be	  helpful	  to	  predict	  which	  patients	  are	  sicker	  to	  optimize	  
resource	  allocation,	  studies	  have	  not	  been	  able	  to	  show	  a	  correlation	  with	  mortality	  and	  
length	  of	  stay	  that	  are	  reliably	  predictable.	  (7,	  8)	  It	  seems	  that	  inter-­‐hospital	  variability	  
in	  practice	  and	  as	  such	  geography	  may	  play	  a	  role	  in	  this	  and	  so	  one	  study,	  CALICO	  
found	  that	  APACHE	  IV	  and	  MPM3	  more	  accurate	  at	  predicting	  ICU	  length	  of	  stay	  in	  
California	  where	  the	  population	  is	  more	  similar	  geographically	  and	  temporally	  to	  
populations	  used	  for	  the	  newer	  models.(9)	  
Resource	  allocation	  can	  also	  be	  improved	  if	  ICU	  length	  of	  stay	  can	  be	  predicted.	  
A	  weighted	  hospital	  days	  model	  was	  created	  based	  on	  four	  variables:	  mortality	  rate,	  
percentage	  of	  unscheduled	  surgical	  patients,	  mechanical	  ventilation	  within	  1	  hour	  of	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ICU	  admission	  and	  patient	  discharge	  to	  post	  acute	  care	  facility.	  (7)	  This	  is	  helpful	  in	  that	  
this	  model	  can	  predict	  at	  an	  ICU	  level	  (not	  individual	  level)	  the	  predicted	  length	  of	  stay.	  
Length	  of	  stay	  will	  be	  discussed	  in	  greater	  detail,	  as	  it	  is	  becoming	  more	  and	  more	  
important	  in	  our	  cost-­‐conscientious	  health	  care	  system.	  
It	  would	  also	  be	  useful	  to	  determine	  which	  patients	  are	  most	  likely	  to	  get	  
readmitted;	  similar	  factors	  are	  used	  to	  predict	  readmission	  rates	  for	  ICU	  but	  no	  
definitive	  model	  has	  emerged	  at	  this	  time.	  (10)	  
3.	  Evaluating	  ICU	  performance	  against	  peer	  units:	  This	  would	  allow	  for	  quality	  
improvement	  and	  standardization	  of	  care	  and	  possibly	  outcomes	  in	  the	  ICU	  by	  
comparing	  patients	  with	  similar	  baseline	  risks	  in	  the	  two	  (or	  more)	  ICU	  settings	  being	  
evaluated	  side-­‐by-­‐side.	  Furthermore,	  it	  would	  allow	  for	  benchmarking,	  i.e.	  allowing	  for	  
a	  comparison	  of	  one	  ICU	  to	  similar	  ICUs	  at	  other	  hospitals	  or	  within	  the	  same	  hospital	  
or	  comparing	  the	  ICU	  to	  itself	  over	  a	  certain	  period	  of	  time.	  	  For	  example,	  studies	  have	  
compared	  open	  and	  closed	  ICUs.	  Severity-­‐of-­‐illness	  scores	  have	  been	  helpful	  in	  
evaluating	  ICU	  performance	  by	  explaining	  variation	  in	  resource	  utilization/costs	  and	  
length	  of	  ICU	  stay.	  	  (11,	  12)	  One	  must	  beware	  of	  referral	  bias	  in	  which	  ICUs	  that	  receive	  
transfer	  patients	  will	  likely	  have	  worse	  outcomes.	  (13-­‐15)	   	  
	  	   4.	  Stratifying	  patient	  by	  extent	  of	  illness	  can	  aid	  in	  research	  design.	  Risk	  
stratification	  allows	  for	  easy	  identification	  of	  patients	  with	  similar	  risk	  who	  then	  can	  
then	  be	  randomized	  for	  randomized	  controlled	  trials.	  (1)	  
Given	  so	  many	  potential	  uses,	  how	  to	  measure	  ICU	  outcomes	  and	  better	  
evaluated	  performance?	  	  Potential	  outcomes	  that	  can	  be	  measured	  include	  mortality,	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morbidity,	  disability,	  cognitive	  dysfunction,	  length	  of	  ICU	  stay,	  cost,	  duration	  of	  ICU	  
therapy,	  nosocomial	  infection	  rates,	  and	  procedure	  complications(1).	  Outcomes	  such	  as	  
morbidity	  and	  mortality	  are	  affected	  by	  multiple	  variables(15,	  16),	  mean	  ICU	  length	  of	  
stay	  is	  skewed	  by	  the	  long	  staying	  outliers(17),	  and	  of	  course	  long	  term	  resource	  use,	  
return	  to	  work,	  quality	  of	  life,	  1-­‐	  or	  5-­‐year	  survival	  require	  intensive	  follow-­‐up(18,	  19).	  
Some	  have	  suggested	  using	  retrospective	  data,	  i.e.	  insurance	  codes	  for	  billing	  to	  obtain	  
diagnoses.	  However,	  in	  very	  ill	  patients,	  especially	  with	  multiple	  morbidities,	  this	  
method	  will	  result	  in	  the	  loss	  of	  additional	  but	  important	  diagnoses	  that	  may	  not	  have	  
been	  coded	  for(20).	  	  
II.	  Severity	  of	  Illness	  Scoring	  Systems:	  General	  concepts	  
For	  the	  purpose	  of	  measuring	  ICU	  outcomes,	  especially	  length	  of	  stay	  and	  
mortality,	  predictive	  scoring	  systems	  evaluating	  specifically	  ICU	  patients	  have	  been	  
developed.	  These	  systems	  take	  into	  account	  several	  clinical	  variables	  including	  
physiologic	  parameters,	  laboratory	  values,	  chronic	  disease	  status,	  neurologic	  function,	  
etc.	  and	  compiles	  it	  into	  a	  numerical	  score	  to	  quantify	  the	  severity	  of	  illness.	  	  In	  some	  
models,	  these	  scores	  can	  be	  plotted	  to	  a	  regression	  that	  can	  give	  a	  prediction	  of	  an	  
outcome,	  for	  example	  the	  outcome	  being	  the	  likelihood	  of	  mortality.	  	  
Four	  major	  predictive	  scoring	  systems	  currently	  exist	  –	  The	  Acute	  Physiologic	  
and	  Chronic	  Health	  Evaluation	  (APACHE)	  systems,	  the	  Simplified	  Acute	  Physiologic	  
Score	  (SAPS)	  the	  Mortality	  Prediction	  Model	  (MPM),	  and	  Sequential	  Organ	  Failure	  
Assessment	  (SOFA).	  As	  a	  side	  note,	  other	  scoring	  systems	  were	  created	  to	  assess	  organ	  
dysfunction,	  trauma	  cases,	  and	  burn	  victims	  but	  here	  the	  focus	  will	  be	  the	  severity	  of	  
illness	  scoring	  systems.	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Generally	  speaking,	  there	  are	  a	  few	  basics	  to	  understanding	  predicative	  scoring	  
systems.	  	  It	  is	  helpful	  to	  have	  a	  brief	  understanding	  of	  how	  to	  develop	  and	  assess	  the	  
predictive	  scoring	  instrument.	  	  
The	  process	  by	  which	  to	  develop	  a	  strong	  and	  sensible	  severity	  of	  illness	  model	  is	  as	  
follows(1):	  
1. define	  outcomes	  (usually	  long-­‐term	  mortality	  or	  functional	  status)	  
2. Identify/define	  predictor	  variables:	  data	  versus	  expert	  opinions*	  
3. collect	  data:	  ensure	  accuracy	  with	  reabstraction/kappa	  analysis**	  
4. examine	  continuous	  variables	  and	  transform	  or	  dichotomize	  	  
5. univariate	  analysis	  against	  outcomes	  
6. multivariate	  analysis	  
7. consider	  interactions	  between	  variables***	  
8. develop	  score	  that	  relates	  variables	  to	  outcome	  
9. test	  calibration:	  Hosmer-­‐Lemeshow	  method	  
10. test	  discrimination:	  ROC	  
11. validate	  model	  with	  independent	  data/split	  sample,	  jackknife	  techniques	  
12. external	  validation	  in	  new	  setting	  
13. publish	  
*Most	  of	  the	  scoring	  systems	  chose	  variables	  to	  include	  such	  as	  physiologic	  data,	  lab	  
values,	  diagnoses	  (acute	  and	  chronic),	  age,	  requirement	  of	  ventilation	  and/or	  
cardiopulmonary	  resuscitation,	  comorbidities/organ	  dysfunction	  (coma/cirrhosis,	  etc.)	  
amongst	  others.	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**Data	  collection	  requires	  large	  populations.	  Most	  of	  the	  scoring	  systems	  use	  patients	  of	  
upwards	  of	  the	  tens	  of	  thousands.	  
***With	  respect	  to	  data	  analysis	  and	  making	  a	  regression,	  limit	  the	  number	  of	  terms	  to	  
10%	  of	  the	  number	  of	  patients	  having	  the	  outcome	  of	  interest	  to	  avoid	  over	  fitting	  the	  
model	  to	  the	  developmental	  dataset.	  	  It	  is	  also	  helpful	  to	  recognize	  additive/cancelling	  
or	  synergistic	  relationships	  between	  terms	  in	  the	  model.	  
The	  most	  common	  measure	  of	  ICU	  performance	  is	  the	  standardized	  mortality	  
ratio	  (SMR),	  which	  is	  ratio	  of	  the	  observed	  mortality	  to	  expected	  mortality	  with	  a	  mean	  
value	  +/-­‐	  the	  95%	  confidence	  interval.	  	  (1)	  	  
Once	  the	  data	  are	  collected	  and	  analysis	  done,	  it	  is	  important	  to	  determine	  
whether	  the	  scoring	  system	  is	  actually	  a	  good	  one	  (see	  #9	  and	  #10):	  one	  that	  is	  
predictive	  and	  accurate.	  This	  is	  done	  by	  analyzing	  the	  regression	  and	  its	  discrimination	  
and	  calibration.	  (21)	  Discrimination	  is	  defined	  as	  the	  accuracy	  of	  a	  given	  prediction	  
from	  the	  regression.	  For	  example,	  if	  the	  predictive	  scoring	  system	  predicts	  a	  mortality	  
of	  85%,	  and	  the	  mortality	  is	  85%	  then	  the	  discrimination	  is	  perfect.	  The	  most	  accepted	  
and	  standard	  way	  to	  determine	  discrimination	  is	  to	  appreciate	  the	  area	  under	  the	  
receiver	  operating	  characteristic	  (ROC)	  curve.	  An	  ROC	  of	  0.5	  is	  no	  better	  than	  chance;	  
values	  >	  0.7	  are	  acceptable,	  0.8	  is	  excellent	  and	  0.9	  is	  outstanding.	  	  (22)	  Calibration	  is	  
defined	  how	  precise	  the	  scoring	  system	  is	  over	  the	  entire	  range	  of	  values.	  For	  example,	  
a	  highly	  predictive	  scoring	  system	  is	  one	  that	  is	  accurate	  at	  mortalities	  of	  10%	  as	  well	  
as	  mortality	  of	  90%	  and	  everything	  in	  between.	  The	  Hosmer-­‐Lemeshow	  C	  statistic	  is	  
used	  for	  this.	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A	  regression	  should	  calibrate	  and	  discriminate	  well	  when	  applied	  to	  a	  new	  
population,	  i.e.	  it	  should	  be	  validated	  in	  a	  separate	  cohort(see	  #12).	  (23)	  Generally	  
speaking,	  populations	  of	  ICU	  admissions	  for	  the	  creating	  a	  scoring	  system	  and	  thus	  
regression	  should	  be	  diverse,	  not	  all	  low	  risk	  or	  specialized	  diagnosis.	  	  (24,	  25)	  Not	  
surprisingly,	  predictive	  scoring	  systems	  cannot	  predict	  outcomes	  for	  populations	  that	  
were	  not	  included	  in	  the	  derivation	  data	  sets.	  	  
Calibration	  can	  be	  affected	  by	  different	  ICU	  types	  as	  mentioned	  above,	  admission	  
diagnoses,	  with	  the	  passage	  of	  time,	  and	  by	  applying	  to	  different	  geographic	  regions.	  
(26)	  First,	  admission	  diagnoses	  can	  make	  a	  tremendous	  difference	  and	  so	  some	  scores	  
have	  been	  especially	  designed	  for	  specific	  diagnoses,	  for	  example	  the	  APACHE	  II	  score	  
for	  pancreatitis.	  	  Second,	  models	  can	  deteriorate	  over	  time	  and	  drift	  out	  of	  calibration	  as	  
interventions/populations	  change,	  so	  the	  models	  need	  to	  be	  constantly	  updated.	  	  
(27)This	  is	  why	  updated	  models	  have	  been	  published	  for	  each	  of	  the	  major	  severity	  of	  
illness	  scores	  every	  10-­‐15	  years.	  	  (5,	  6,	  28-­‐35)	  Third,	  location	  matters	  and	  so	  a	  model	  
may	  only	  be	  applicable	  in	  certain	  geographic	  settings.	  New	  validation/recalibration	  
may	  be	  necessary	  if	  applied	  to	  new	  geographic	  settings.	  	  (36)	  The	  reasons	  for	  
differences	  in	  calibration	  with	  geography	  include	  regional	  differences	  in	  practices	  of	  
care,	  differences	  in	  acuity	  mix,	  or	  differences	  in	  the	  age	  of	  the	  patient	  population.	  	  (26)	  
To	  correct	  for	  this	  geographical	  factor,	  some	  European	  governments	  have	  used	  only	  
patients	  from	  their	  country	  to	  better	  calibrate	  the	  severity	  of	  illness	  score	  that	  they	  are	  
employing	  for	  their	  ICU	  patients.	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Another	  interesting	  facet	  of	  interpreting	  severity	  of	  illness	  metrics	  is	  
appreciating	  how	  one’s	  individual	  ICU’s	  operations	  and	  processes	  differ	  from	  the	  
reference	  ICUs	  used	  to	  built	  the	  severity	  of	  illness	  models.	  	  (26)	  Some	  hospitals	  may	  
easily	  be	  able	  to	  transfer	  patients	  to	  other	  hospitals,	  which	  would	  result	  in	  lower	  
mortality	  rates.	  	  Conversely,	  tertiary	  care	  centers	  do	  not	  have	  that	  option	  and	  so	  may	  
have	  higher	  mortality	  rates.	  	  Another	  issues	  may	  be	  that	  some	  hospitals	  may	  have	  
better	  and	  easier	  access	  to	  alternative	  care	  sites,	  such	  as	  long-­‐term	  acute	  care	  facilities,	  
and	  so	  fewer	  of	  these	  patients	  will	  stay	  long	  enough	  in	  the	  ICU	  to	  pass	  away	  there.	  Most	  
obviously,	  available	  resources	  within	  the	  ICU,	  quality	  of	  sign	  out	  and	  transition	  from	  
shift-­‐to-­‐shift	  by	  the	  staff,	  and	  cooperation	  between	  different	  teams	  providing	  services	  
for	  the	  same	  patient	  will	  also	  affect	  morbidity	  and	  mortality.	  	  
Current	  scoring	  systems	  are	  not	  perfect	  and	  there	  are	  many	  biases	  and	  problems	  
to	  consider.	  For	  example,	  oftentimes	  physicians	  and	  nurses	  have	  better	  intuition	  in	  
figuring	  out	  survivors	  and	  non-­‐survivors	  than	  these	  scores	  and	  so	  the	  scores	  may	  not	  be	  
actually	  helpful	  for	  individual	  patients.	  (37)	  Another	  issue	  is	  that	  ICU	  patients	  who	  
come	  through	  the	  emergency	  department	  are	  stabilized	  by	  the	  emergency	  department	  
physician	  so	  that	  they	  have	  lower	  ICU	  admission	  scores,	  although	  they	  may	  in	  fact	  be	  
very	  sick.	  The	  converse	  is	  that	  ICU	  patients	  who	  do	  not	  come	  through	  an	  emergency	  
department	  may	  in	  fact	  have	  very	  abnormal	  vital	  signs	  that	  may	  predict	  higher	  
mortality	  predictions	  but	  these	  vital	  signs	  may	  correct	  with	  some	  basic	  treatments	  –	  
this	  creating	  a	  lower	  actual-­‐to-­‐predicted	  mortality	  ratio)	  and	  improving	  the	  mortality	  
and	  outcome	  statistics	  for	  that	  ICU.	  	  	  (38)	  And	  yet	  another	  example	  is	  that	  by	  the	  24-­‐
hour	  point	  in	  the	  ICU,	  a	  treatment	  has	  usually	  already	  been	  given	  and	  the	  speed	  and	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correctness	  with	  which	  the	  intervention	  was	  done	  will	  affect	  the	  patient’s	  score	  and	  
mortality/prognosis.	  	  (39)	  Finally,	  most	  of	  the	  scoring	  systems	  are	  specific	  but	  
insensitive	  in	  predicting	  death.(1)	  In	  general	  they	  are	  excellent	  for	  assessing	  ICU	  
performance	  by	  comparing	  outcomes	  within	  the	  treated	  population	  to	  reference	  
population	  used	  to	  develop	  and	  validate	  the	  score.	  	  (26)	  However,	  there	  has	  been	  little	  
utility	  for	  these	  scores	  with	  respect	  to	  managing	  individual	  patients	  and	  since	  
physician/nursing	  intuition	  is	  as	  good	  as	  the	  score,	  there	  has	  been	  very	  little	  utility	  for	  
it	  in	  predicting	  individual	  patient	  outcomes	  unless	  the	  scores	  are	  specific	  to	  a	  diagnosis,	  
e..g	  APACHE	  II	  and	  acute	  pancreatitis.	  	  
Perhaps	  an	  even	  greater	  pitfall	  is	  misapplication	  of	  the	  scoring	  system	  by	  the	  user	  
herself.	  Some	  of	  the	  pitfalls	  in	  the	  application	  of	  these	  systems	  include	  
1. data	  collection	  and	  entry	  error:	  the	  user	  may	  incorrectly	  include	  ineligible	  
patients,	  forget	  or	  be	  missing	  certain	  variables,	  incorrectly	  transcribe	  the	  data,	  	  
or	  select	  the	  wrong	  diagnosis.	  Miscommunication	  between	  hospital	  clinical	  and	  
risk	  adjustment	  applications	  may	  also	  results	  in	  errors.	  	  (40)	  
2. Misapplication	  of	  the	  model:	  This	  can	  occur	  if	  there	  are	  case-­‐mix	  differences,	  if	  
the	  model	  is	  applied	  to	  only	  subsets	  of	  the	  populations	  used	  to	  develop	  the	  
model,	  if	  certain	  variables	  are	  influenced	  by	  improvements	  in	  medical	  care,	  if	  
there	  is	  lead	  time	  bias	  (transfers),	  and	  if	  small	  clinical	  changes	  correlate	  to	  large	  
risks	  when	  continuous	  data	  are	  sorted	  into	  discrete	  data	  and	  categorized.	  	  (15,	  
24,	  41)	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3. Use	  of	  mortality	  as	  the	  sole	  criterion	  of	  outcome:	  This	  may	  be	  skewed	  by	  
patients	  lost	  to	  follow-­‐up,	  factors	  related	  to	  chance,	  the	  role	  of	  resources	  and	  
costs,	  etc.	  
4. 	  Failure	  to	  account	  for	  sample	  size	  and	  chance	  variability:	  This	  may	  occur	  with	  a	  
small	  sample	  size,	  computational	  errors,	  misapplication	  of	  group	  data	  to	  the	  
individual,	  and	  misinterpretation	  of	  statistical	  significance	  to	  suggest	  clinical	  
significance.	  	  (42-­‐44)	  
	   At	  this	  point	  in	  time,	  ICU	  scoring	  systems	  are	  currently	  used	  in	  approximately	  
10-­‐15%	  of	  US	  ICU	  patients.	  	  (26)The	  belief	  is	  that	  this	  will	  increase	  as	  costs	  associated	  
with	  manual	  data	  collection	  disappear	  as	  more	  and	  more	  health	  care	  systems	  adopt	  
electronic	  charting.	  	  Although	  not	  perfect,	  ICU	  scoring	  systems	  are	  considered	  the	  best	  
measure	  of	  outcome-­‐focused	  ICU	  quality	  and	  performance	  that	  currently	  exists.	  It	  is	  
continually	  calibrated	  and	  in	  our	  modern	  day	  emphasis	  on	  objective	  evidence	  of	  
outcomes,	  it	  would	  be	  a	  failure	  not	  to	  employ	  the	  ICU	  scoring	  systems.	  	  (26)	  
III.	  Severity	  of	  Illness	  Scoring	  Systems:	  specifics	  	  
Each	  of	  the	  four	  major	  severity	  of	  illness	  scores	  is	  unique	  and	  a	  short	  discussion	  
of	  each	  is	  merited	  to	  understand	  its	  application,	  strengths,	  flaws,	  and	  utility.	  	  
The	  APACHE	  II	  score	  is	  the	  most	  commonly	  used	  score.	  	  Twelve	  variables	  go	  into	  
creating	  the	  predictive	  score	  and	  the	  worst	  value	  for	  each	  variable	  is	  used	  from	  the	  
initial	  24	  hours	  after	  admission	  to	  the	  ICU.	  	  (28)	  Thus	  a	  major	  drawback	  is	  that	  patients	  
have,	  for	  the	  most	  part,	  already	  received	  an	  intervention	  by	  the	  time	  a	  score	  is	  
calculated.	  The	  variables	  are	  weighted	  equally	  except	  those	  markers	  for	  neurologic	  and	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renal	  function,	  specifically	  Glasgow	  coma	  score	  and	  serum	  creatinine,	  which	  are	  
weighted	  higher.	  All	  twelve	  variables	  are	  necessary	  to	  calculate	  the	  score.	  The	  worst	  
score	  is	  71	  and	  lower	  scores	  are	  better.	  The	  scores	  directly	  correlate	  to	  observed	  
hospital	  death	  rate	  and	  broken	  into	  increments	  of	  5	  points.	  For	  patients	  with	  scores	  of	  
0-­‐4,	  the	  death	  rate	  was	  1.9%	  by	  hospital	  discharge.	  On	  the	  flip	  side,	  patients	  with	  scores	  
of	  30-­‐34	  have	  a	  73%	  death	  rate	  and	  84%	  and	  higher	  for	  patients	  with	  scores	  greater	  
than	  35.	  With	  respect	  to	  estimating	  individual	  death	  rates,	  the	  overall	  correct	  
classification	  rate	  was	  86%	  with	  decreasing	  false	  positive	  rates	  as	  scores	  increase.	  But	  
clinicians	  do	  not	  use	  the	  APACHE	  II	  to	  accurate	  predict	  outcomes.	  Discrimination	  is	  
excellent	  for	  this	  instrument	  but	  the	  calibration	  is	  not	  perfect	  and	  requires	  constant	  
updating.	  While,	  APACHE	  II	  is	  the	  most	  frequently	  employed	  scoring	  system,	  the	  most	  
recent	  is	  APACHE	  IV,	  which	  has	  more	  variables,	  a	  new	  logistical	  regression	  equation	  
and	  a	  new	  statistical	  modeling.	  	  (45,	  46)	  APACHE	  IV	  was	  determined	  by	  an	  
observational	  study	  of	  110,	  588	  ICU	  admissions	  and	  can	  more	  accurately	  predict	  
mortality	  and	  ICU	  length	  of	  stay	  than	  previous	  models.	  (6)	  
The	  SAPS	  II	  scoring	  system	  uses	  17	  variables	  and	  calculates	  a	  severity	  score	  
using	  the	  worst	  values	  measured	  during	  the	  first	  24	  hours	  after	  admission	  to	  the	  ICU.	  
Some	  variables	  are	  continuous	  and	  assigned	  points	  based	  on	  which	  range	  set	  it	  falls	  into.	  
Others	  are	  dichotomous,	  assigned	  1	  for	  present	  or	  0	  for	  absent.	  The	  scores	  can	  predict	  
hospital	  mortality	  rate	  when	  input	  into	  a	  mathematical	  formula.	  The	  SAPS	  II	  is	  the	  most	  
commonly	  used	  model	  of	  the	  SAPS	  series	  and	  was	  based	  on	  data	  from	  8500	  patients.	  
(	  (34)It	  has	  excellent	  discrimination	  and	  calibration	  but	  is	  less	  accurate	  for	  patients	  
who	  are	  admitted	  to	  the	  ICU	  for	  non-­‐cardiovascular	  disease.	  	  (47,	  48)	  The	  more	  recent	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version,	  SAPS	  III,	  has	  been	  found	  in	  validation	  studies	  to	  have	  excellent	  discrimination	  
but	  poor	  calibration.	  	  (30,	  49)	  
The	  MPM	  II	  scoring	  system	  utilizes	  15	  variables	  and	  calculates	  a	  severity	  score	  
using	  the	  value	  collected	  at	  the	  time	  of	  ICU	  admission	  for	  each	  variable.	  All	  the	  variables	  
except	  for	  age	  are	  dichotomous	  and	  the	  score	  can	  be	  recalculated	  every	  24	  hours	  to	  
provide	  an	  updated	  assessment	  of	  the	  patient	  and	  also	  to	  compare	  it	  to	  the	  SAPS	  and	  
APACHE	  scores.	  	  The	  MPM	  II	  was	  based	  on	  data	  from	  over	  12,500	  patients	  and	  was	  
shown	  to	  have	  excellent	  calibration	  and	  discrimination.	  (31)The	  updated	  version	  
MPM0-­‐III	  also	  has	  excellent	  calibration	  when	  validated	  over	  a	  cohort	  of	  55,000	  ICU	  
patients.	  	  (50)	  
The	  SOFA	  utilizes	  measurements	  of	  organ	  function	  (respiratory,	  cardiovascular,	  
hepatic,	  coagulation,	  neurologic,	  and	  renal)	  to	  calculate	  a	  severity	  score.	  Scores	  are	  
calculated	  at	  24	  hours	  after	  admission	  to	  the	  ICU	  and	  every	  24	  hours	  after.	  The	  mean	  
and	  the	  highest	  scores	  are	  most	  predictive	  of	  mortality.	  Scores	  that	  increase	  
substantially	  (30%	  or	  more)	  are	  associated	  with	  a	  mortality	  rate	  of	  >50%.	  (20)	  This	  
scoring	  system	  was	  derived	  from	  data	  gathered	  from	  1449	  patients	  admitted	  to	  40	  ICUs	  
in	  16	  countries.	  	  (51)	  
IV.	  Comparison	  of	  the	  Severity	  of	  Illness	  Scores	  
Briefly,	  overall,	  the	  efficacy	  of	  the	  APACHE	  scoring	  system	  appears	  to	  be	  
superior.	  	  (52)	  One	  retrospective	  study	  comparing	  MPM	  II,	  SAPS	  II	  and	  APACHE	  IV	  
showed	  that	  APACHE	  IV	  was	  most	  accurate	  but	  the	  MPM	  III	  is	  a	  better	  instrument	  if	  
cost	  and	  complexity	  of	  data	  collection	  are	  factored	  in.	  (44)	  A	  systematic	  review	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comparing	  SOFA,	  SAPS	  II,	  and	  APACHE	  II	  and	  III	  found	  that	  the	  APACHE	  systems	  were	  
better	  at	  predicting	  ICU	  mortality.	  	  (53)	  However,	  the	  APACHE	  III	  and	  IV	  systems	  
require	  proprietary	  computer	  technology	  and	  substantial	  data	  collection.	  This	  extra	  
cost	  makes	  the	  APACHE	  systems	  prohibitively	  expensive	  for	  most	  ICUs.	  The	  other	  
scoring	  systems	  require	  less	  data	  collection	  and	  no	  technologic	  investment	  and	  are	  
therefore	  more	  commonly	  used	  in	  the	  ICU	  setting.	  Interestingly,	  the	  variables	  for	  the	  
APACHE	  II	  system	  were	  randomly	  chosen	  where	  as	  the	  variables	  for	  MPM	  II,	  SAPS	  II,	  
and	  APACHE	  IV	  have	  all	  been	  shown	  to	  independently	  predict	  mortality.	  	  (6,	  28,	  30,	  34)	  
Predicting	  ICU	  length	  of	  stay	  is	  of	  appreciable	  importance	  in	  today’s	  health	  care	  
system	  as	  there	  is	  growing	  interest	  in	  reducing	  health	  care	  costs.	  APACHE	  was	  the	  only	  
scoring	  system	  that	  has	  been	  shown	  to	  have	  good	  discrimination	  and	  calibration	  in	  
predicting	  ICU	  and	  hospital	  length	  of	  stay	  in	  US	  ICUs.	  	  (26)	  MPM	  was	  shown	  to	  predict	  
ICU	  length	  of	  stay	  adequately	  in	  California	  hospitals.	  (9)	  
Additionally,	  the	  scores	  have	  been	  customized	  to	  fit	  a	  specific	  patient	  population.	  
APACHE	  was	  fit	  to	  the	  Veteran	  Administration	  hospital	  system	  in	  the	  United	  States,	  
California	  ICU	  Outcomes	  Study/CalHospitalCompare	  project	  worked	  with	  the	  MPM,	  
APACHE,	  and	  SAPS	  scoring	  systems,	  the	  Netherlands	  used	  APACHE	  II,	  MPM-­‐admit	  III,	  
and	  SAPS2,	  and	  Great	  Britain	  adapted	  the	  APACHE	  II	  scoring.	  (9,	  54-­‐57)	  These	  
adaptions	  were	  made	  by	  using	  either	  first-­‐level	  customization	  or	  second-­‐level	  
customization.	  First	  level	  customization	  is	  the	  use	  of	  the	  same	  variable	  weights	  that	  
were	  used	  in	  the	  original	  index	  but	  readjustment	  of	  the	  regression	  equation	  so	  that	  it	  
better	  fits	  the	  patient	  population	  to	  which	  the	  user	  wishes	  to	  apply	  it.	  Second	  level	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customization	  involves	  changing	  the	  weights	  of	  the	  variable	  as	  well	  readjusting	  the	  
regression	  equation.	  	  
V.	  A	  prognostic	  score	  based	  on	  intraoperative	  data:	  the	  APGAR	  score	  
More	  recently,	  Gawande,	  et.	  al	  surmised	  that	  medical	  staffing	  could	  
tremendously	  benefit	  from	  a	  more	  simple	  score	  than	  the	  current	  severity	  of	  illness	  
scoring	  systems	  for	  surgical	  patients	  going	  to	  the	  ICU.	  	  (58)The	  current	  scores	  require	  
too	  many	  data	  elements,	  the	  scores	  are	  too	  bulky	  to	  quickly	  calculate	  on	  the	  fly,	  
oftentimes	  all	  the	  variables	  are	  not	  uniformly	  collected	  for	  each	  patient,	  rendering	  them	  
useless.,	  and	  most	  scores	  are	  not	  useful	  in	  predicting	  outcomes	  of	  individual	  patients.	  
The	  goal	  was	  to	  create	  a	  simple	  score	  that	  could	  easily	  be	  calculated	  at	  the	  bedside	  and	  
be	  used	  to	  predict	  which	  individual	  post-­‐operative	  patients	  in	  the	  ICU	  might	  have	  
complications	  and/or	  poor	  outcomes	  and	  thus	  require	  more	  monitoring,	  attention,	  and	  
intervention	  by	  the	  medical	  staff	  in	  the	  ICU.	  	  
Rather	  than	  looking	  at	  data	  from	  the	  ICU,	  i.e.	  after	  the	  patient	  has	  already	  arrived	  
in	  the	  unit,	  these	  studies	  focused	  on	  perioperative	  data	  to	  calculate	  a	  simple	  score	  that	  
could	  then	  serve	  as	  an	  alert	  for	  staff	  before	  or	  just	  as	  the	  patient	  even	  arrives	  in	  the	  ICU.	  
Patients	  undergoing	  major	  general	  or	  vascular	  surgery	  were	  enrolled	  in	  the	  study	  and	  
28	  variables	  from	  the	  intraoperative	  anesthesia	  records	  were	  collected	  and	  analyzed	  
with	  the	  primary	  outcomes	  measured	  as	  death	  or	  major	  complications	  (acute	  renal	  
failure,	  bleeding	  requiring	  transfusion	  of	  4	  or	  more	  units	  of	  packed	  red	  blood	  cells	  
within	  72	  hours	  after	  surgery,	  cardiac	  arrest	  requiring	  CPR,	  coma	  for	  24	  hours	  or	  longer,	  
deep	  vein	  thrombosis,	  septic	  shock,	  myocardial	  infarction,	  unplanned	  intubation,	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ventilator	  use	  for	  48	  hours	  or	  more,	  pneumonia,	  pulmonary	  embolism,	  stroke,	  wound	  
disruption,	  deep	  or	  organ-­‐space	  surgical	  site	  infection,	  sepsis,	  systemic	  inflammatory	  
response	  syndrome,	  vascular	  graft	  failure,	  anastomotic	  leak,	  cystic	  duct	  leak	  after	  
cholecystectomy,	  pericardial	  effusion	  requiring	  drainage,	  and	  gastric	  outlet	  obstruction	  
requiring	  reoperation)	  within	  30	  days	  after	  the	  operation.	  	  Variables	  that	  were	  shown	  
in	  univariate	  analysis	  to	  independently	  predict	  major	  complications	  or	  death	  were	  
plugged	  into	  a	  regression	  equation	  that	  weighted	  the	  variable	  on	  a	  10	  point	  score,	  
where	  each	  1	  point	  increase	  would	  produce	  an	  equivalent	  increase	  in	  the	  odds	  of	  
complication.	  A	  multivariate	  analysis	  and	  logistical	  regression	  was	  derived	  and	  tested	  
for	  calibration	  and	  discrimination.	  	  The	  end	  result	  was	  a	  10	  point	  score	  based	  on	  lowest	  
heart	  rate,	  log	  estimated	  blood	  loss	  and	  lowest	  mean	  arterial	  pressure.	  (see	  table	  3).	  
Lower	  scores	  correlated	  to	  worse	  outcomes.	  The	  score	  was	  applied	  to	  a	  separate	  cohort	  
of	  patients.	  Twenty	  percent	  of	  patients	  had	  scores	  of	  9	  or	  10	  and	  those	  patients	  
experience	  a	  <	  4%incidence	  of	  major	  complications	  and	  no	  deaths.	  In	  contrast	  4%	  of	  
patients,	  much	  fewer,	  had	  scores	  of	  <	  or	  =	  4	  but	  they	  had	  a	  >50%	  risk	  of	  major	  
complications	  and	  a	  14%	  mortality	  rate.	  Even	  with	  the	  low	  prevalence	  at	  the	  high	  risk	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   Odds	  ratio	   95%	  Confidence	  
interval	  
P	  value	  
Lowest	  heart	  rate	   1.06	   1.03-­‐1.08	   <0.0001	  
Log	  estimated	  blood	  loss	   1.82	   1.08-­‐3.07	   0.002	  
Lowest	  mean	  arterial	  pressure	   0.96	   0.93-­‐0.99	   0.002	  
	  
Table	  1.	  APGAR	  score:	  characteristics	  associated	  with	  major	  complications	  and	  death	  
for	  303	  colectomy	  patients:	  multivariable	  analysis	  
	  
The	  initial	  study	  was	  expanded	  to	  4119	  general	  and	  vascular	  surgery	  patients.	  Of	  
those,	  1441	  patients	  had	  scores	  of	  9-­‐10	  with	  a	  major	  complication	  rate	  of	  5%	  and	  death	  
rate	  of	  0.1%.	  of	  the	  128	  patients	  with	  scores	  of	  4	  or	  less,	  the	  relative	  risk	  of	  major	  
complication	  was	  56.3%	  	  (11.3	  95%	  confidence	  interval)	  and	  the	  a	  relative	  risk	  of	  	  
death	  was	  19.5%	  (140.7	  95%	  confidence	  interval).	  	  (59)The	  C	  statistics	  were	  0.73	  for	  
major	  complications	  and	  0.81	  for	  deaths.	  
Further	  studies	  by	  the	  same	  group	  accounted	  for	  fixed	  preoperative	  risk,	  
secondary	  to	  patients’	  acute	  conditions,	  comorbidities,	  or	  the	  complexity	  of	  the	  
operation.	  Even	  in	  patients	  with	  equivalent	  preoperative	  predictions,	  higher	  surgical	  
Apgar	  scores	  still	  predicted	  lower	  odds	  of	  major	  complications	  and	  lower	  scores	  higher	  
odds.	  	  	  (60)	  Gawande,	  et	  al	  also	  expanded	  the	  use	  of	  the	  score	  to	  other	  surgical	  sub-­‐
specialties	  and	  found	  some	  utility	  in	  this	  for	  many	  other	  surgical	  services.	  It	  has	  
additionally	  be	  expanded	  and	  validated	  in	  a	  global	  patient	  population	  –in	  8	  other	  
countries.	  (61)	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The	  Surgical	  Apgar	  score	  has	  several	  major	  benefits	  and	  purposes.	  It	  is	  useful	  in	  
backing	  up	  a	  team’s	  “gut	  feeling”	  about	  how	  well	  the	  operation	  went	  and	  how	  well	  the	  
patient	  faired	  through	  the	  operation.	  It	  is	  simple	  to	  calculate,	  available	  immediately,	  
objective,	  and	  easy	  to	  communicate	  by	  the	  teams,	  and	  helpful	  in	  decision	  making	  for	  
management	  and	  increasing	  monitoring.	  	  (59)In	  the	  future,	  it	  may	  be	  helpful	  in	  
decision-­‐making	  for	  which	  patients	  should	  be	  admitted	  to	  the	  ICU	  post-­‐operatively	  as	  
well	  as	  for	  quality	  monitoring.	  	  
Of	  note,	  there	  are	  a	  few	  shortcomings	  and	  criticisms	  of	  the	  score.	  This	  score	  
cannot	  be	  used	  for	  the	  comparison	  of	  quality	  between	  different	  institutions	  or	  
practitioners	  since	  each	  of	  the	  variables	  is	  influenced	  by	  both	  the	  patient’s	  prior	  
condition	  but	  also	  the	  interventions	  of	  the	  medical/surgical	  teams.	  Of	  course,	  estimated	  
blood	  loss	  is	  not	  exact	  and	  so	  the	  anesthesiologist	  is	  relied	  upon	  to	  avoid	  any	  bias	  on	  the	  
part	  of	  the	  surgical	  team.	  Even	  so,	  it	  is	  an	  estimate	  and	  therefore	  imprecise.	  The	  
hemodynamic	  variables	  are	  also	  subject	  to	  being	  affected	  by	  anesthetic	  medications	  and	  
how	  reactive	  the	  anesthesiologist	  is	  to	  certain	  hemodynamic	  thresholds.	  Moreover	  
transient	  hypotension	  and	  prolonged	  hypotension	  result	  in	  the	  same	  score	  although	  
one	  may	  actually	  be	  worse	  than	  the	  other.	  The	  risk	  of	  intra	  operative	  hypotension	  is	  
higher	  in	  patients	  who	  have	  a	  preoperative	  mean	  arterial	  pressure	  (MAP)	  >	  or	  =	  to	  110,	  
a	  walking	  distance	  of	  less	  than	  400	  m,	  plasma	  volume	  of	  less	  than	  3000	  cc,	  having	  intra-­‐
abdominal	  or	  vascular	  surgery,	  surgery	  that	  is	  longer	  than	  2	  hours,	  and	  elderly	  with	  
reduced	  plasma	  volume.	  	  (62)	  Regardless	  the	  cause,	  hypotension	  persistently	  elevated	  
heart	  rates	  and	  are	  associated	  with	  poorer	  outcomes.	  (63)	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VI.	  Cardiovascular	  stability:	  better	  marker	  of	  prognosis?	  
How	  then	  can	  we	  improve	  on	  this	  surgical	  Apgar	  score?	  Thus	  far,	  all	  of	  the	  ICU	  
severity	  scores	  and	  APGAR	  metric	  consider	  either	  admission	  data	  or	  worst	  score	  over	  a	  
24-­‐hour	  period	  and	  do	  not	  comment	  on	  variability	  or	  lability.	  We	  would	  like	  to	  explore	  
beyond	  this	  norm	  and	  assess	  what	  sort	  of	  effect	  fluctuations	  in	  physiologic	  factors,	  
specifically	  cardiovascular	  vital	  signs,	  in	  the	  intraoperative	  and	  postoperative	  setting	  
has	  with	  respect	  to	  patient	  outcomes.	  	  
Variability	  in	  beat-­‐to-­‐beat	  interval	  of	  the	  heart	  rate	  has	  been	  well-­‐studied.	  
Physiologically,	  the	  sinoatrial	  node	  has	  its	  own	  intrinsic	  rate	  and	  is	  modulated	  by	  the	  
autonomic	  system	  especially	  the	  vagal	  nerve	  and	  catecholamines	  as	  well	  as	  the	  
baroreflex,	  thermoregulation,	  hormones,	  respiration,	  physical	  activity,	  stress,	  meals	  and	  
the	  sleep-­‐wake	  cycle.	  Decreased	  parasympathetics	  or	  increased	  sympathetic	  activity	  
will	  result	  in	  reduced	  heart	  rate	  variation.	  Measuring	  variability	  can	  be	  difficult	  because	  
of	  artifact	  especially	  with	  motion,	  muscle	  contraction,	  vocalization,	  and	  electrode	  
movement.	  Endurance	  athletes	  have	  higher	  heart	  rate	  variability	  (HRV),	  possibly	  due	  to	  
exercise	  or	  perhaps	  due	  to	  a	  genetic	  component.	  	  (64)It	  has	  been	  shown	  that	  heart	  rate	  
variability	  has	  some	  genetic	  component.	  Also	  of	  note,	  many	  drugs	  can	  affect	  heart	  rate	  
variability	  and	  these	  include	  anticholinergics,	  beta	  blockers,	  calcium	  channel	  blockers,	  
digoxin,	  ACE	  inhibitors,	  and	  antiarrhythmics.	  	  
There	  are	  a	  number	  of	  measures	  of	  heart	  rate	  variability,	  which	  do	  not	  need	  to	  
be	  discussed	  in	  great	  depth	  for	  this	  project.	  (Please	  refer	  to	  the	  appendix)	  
Measures	  of	  heart	  rate	  variability	  are	  clinically	  useful	  in	  many	  settings	  and	  the	  
most	  commonly	  uses	  are	  1.	  For	  the	  prediction	  of	  the	  risk	  of	  cardiac	  death	  or	  arrhythmia	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after	  myocardial	  infarction	  and	  2.	  To	  detect	  and	  assess	  the	  extent	  of	  autonomic	  
neuropathy	  in	  patients	  with	  diabetes.	  (65)	  
In	  post	  myocardial	  infarction	  patients,	  the	  beat-­‐to-­‐beat	  (RR)	  variability	  is	  
significant	  depressed.	  	  (66)	  Moreover,	  it	  may	  be	  associated	  with	  sympathetic	  state	  that	  
could	  result	  in	  arrhythmogenesis.	  Beat-­‐to-­‐beat	  variability	  is	  not	  useful	  in	  predicting	  
recurrent	  infarction	  nor	  is	  it	  predictive	  of	  poor	  outcomes	  in	  patients	  with	  angina.	  	  
	  (67)	  
In	  the	  general	  population,	  low	  RR	  variability	  is	  associated	  with	  mortality	  and	  the	  
risk	  of	  cardiac	  events	  	  (68).	  	  Studies	  have	  confirmed	  this	  in	  healthy	  patients	  and	  in	  
patients	  referred	  for	  24-­‐hour	  Holter	  monitor	  recordings.	  Patients	  with	  lower	  RR	  
variability	  have	  been	  shown	  to	  have	  a	  higher	  risk	  of	  coronary	  heart	  disease	  when	  
adjusted	  for	  other	  cardiovascular	  risk	  factors.	  	  (69,	  70)	  Limited	  data	  suggest	  that	  beat-­‐
to-­‐beat	  variability	  may	  be	  of	  predictive	  value	  in	  heart	  failure	  specifically	  in	  patients	  
with	  dilated	  cardiomyopathy	  and	  congestive	  heart	  failure.	  	  (71-­‐76)	  Abnormal	  heart	  rate	  
variability	  may	  also	  predict	  early	  recurrence	  of	  atrial	  fibrillation	  after	  cardio	  version.	  	  
(77)	  
In	  the	  SICU,	  depressed	  HRV	  have	  been	  associated	  with	  worse	  outcomes.	  	  (78)	  
Studies	  have	  shown	  that	  HRV	  parameters	  are	  predictive	  of	  ICU	  length	  of	  stay	  post	  
coronary	  artery	  bypass	  surgery	  and	  following	  abdominal	  aortic	  surgery	  	  (79,	  80).	  Poor	  
outcomes	  of	  neurological	  injury	  especially	  stroke	  are	  correlated	  with	  heart	  rate	  and	  
blood	  pressure	  variability	  both	  in	  children	  	  (81)	  and	  adults	  	  (82)	  perhaps	  indicative	  of	  
the	  extent	  of	  injury	  to	  the	  autonomic	  nervous	  system.	  (83)	  In	  sepsis,	  HRV	  indices	  have	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been	  shown	  to	  be	  helpful	  in	  diagnostically	  as	  well	  as	  to	  monitor	  improvement	  and	  
recovery	  	  (84,	  85).	  	  
Thus,	  beat-­‐to-­‐beat	  variability	  has	  been	  well	  studied	  and	  characterized.	  In	  our	  
study	  we	  are	  interested	  in	  studying	  variations	  of	  heart	  rate	  of	  longer	  periods	  of	  time.	  
Heart	  rate	  over	  longer	  periods	  adjusts	  to	  maintain	  cardiac	  output	  as	  cardiac	  output	  is	  
the	  product	  of	  heart	  rate	  and	  stroke	  volume.	  As	  demand	  increases,	  cardiac	  output	  also	  
increases.	  We	  expect	  that	  in	  our	  ICU	  patients	  that	  large	  variations	  in	  heart	  rate	  over	  
hours	  and	  days	  (not	  beat-­‐to-­‐beat	  variability)	  will	  be	  an	  important	  factor	  in	  predicting	  
poor	  patient	  outcomes.	  	  
Variability	  in	  blood	  pressure	  has	  not	  been	  studied	  as	  thoroughly.	  Broadly,	  night	  
time	  dipping	  of	  blood	  pressure,	  defined	  as	  a	  reduction	  in	  the	  mean	  nighttime	  blood	  
pressure	  to	  levels	  <90%	  of	  mean	  day	  time	  levels,	  is	  not	  concerning	  and	  in	  fact	  is	  
considered	  favorable	  in	  cardiovascular	  prognosis.	  	  (86)	  Therefore,	  when	  studying	  
shorter-­‐term	  variability	  in	  blood	  pressure	  it	  is	  important	  to	  note	  this	  type	  of	  variation	  is	  
physiologic.	  	  Higher	  than	  normal	  blood	  pressure	  variability	  is	  seen	  in	  essential	  
hypertension.	  (87)	  In	  animal	  models,	  increases	  in	  short	  term	  blood	  pressure	  variability	  
(BPVar)	  is	  associated	  with	  poor	  outcomes	  such	  as	  biventricular	  hypertrophy,	  
atherosclerosis,	  structural	  damage	  to	  heart	  and	  kidneys	  and	  adverse	  arterial	  
remodeling.	  	  (88,	  89)	  Data	  in	  humans	  shows	  that	  for	  higher	  than	  base-­‐line	  BPVar	  is	  
associated	  with	  higher	  rates	  of	  cardiovascular	  morbidity,	  stroke,	  target	  organ	  damage	  
scores,	  progression	  of	  carotid	  intima	  to	  medial	  wall	  thickness	  and	  left	  ventricular	  
hypertrophy.	  	  (90-­‐93)	  One	  large	  sample	  of	  the	  general	  population	  showed	  that	  a	  higher	  
than	  average	  standard	  deviation	  of	  systolic	  and	  diastolic	  blood	  pressure	  was	  associated	  
3/5/2012	  10:40	  PM	   Thesis	  Page	  21	  
	  
	  
with	  greater	  cardiovascular	  mortality	  at	  mean	  follow-­‐up	  of	  8.5	  years.	  	  (94)	  No	  data	  exist	  
on	  short-­‐term	  consequences	  of	  increased	  blood	  pressure	  variability/lability	  in	  the	  ICU.	  
Of	  note,	  studies	  use	  both	  arterial	  lines	  and	  non-­‐invasive	  monitoring	  to	  access	  variability	  
in	  blood	  pressure.	  	  (87)	  
	   While	  studies	  on	  beat-­‐to-­‐beat	  heart	  rate	  variability	  and	  blood	  pressure	  
variability	  have	  been	  reported	  in	  the	  literature,	  we	  wish	  to	  formally	  study	  longer	  
periods	  of	  lability	  (minutes	  to	  hours)	  in	  cardiovascular	  parameter.	  Physiologically,	  the	  
mechanisms	  are	  well	  understood.	  
	   Changes	  in	  heart	  rate	  reflect	  the	  cardiovascular	  system’s	  ability	  to	  adjust	  cardiac	  
output.	  	  (95)Classically,	  heart	  rate	  multiplied	  by	  the	  stroke	  volume	  determines	  cardiac	  
output.	  Cardiac	  output	  is	  determined	  by	  workload	  and	  oxygen	  consumption,	  and	  heart	  
rate	  correlates	  linearly	  with	  both	  of	  these.	  Heart	  rate	  at	  any	  workload	  is	  higher	  in	  an	  
unfit	  person	  than	  a	  fit	  person	  because	  the	  workload	  uses	  a	  greater	  capacity	  of	  muscle	  
power	  of	  the	  unfit	  person.	  	  (96)Similarly,	  females	  have	  a	  higher	  heart	  rate	  at	  the	  same	  
workload	  because	  the	  average	  maximum	  oxygen	  consumption	  is	  higher	  in	  males	  as	  a	  
result	  of	  larger	  muscle	  mass.	  Thus,	  if	  workload	  is	  normalized	  to	  the	  maximum	  capacity,	  
then	  heart	  rate	  can	  be	  determined	  as	  a	  percentage	  of	  that	  maximum	  capacity.	  Thus	  
cardiac	  output	  is	  regulated	  by	  absolute	  workload	  and	  heart	  rate	  by	  relative	  workload.	  	  
The	  theoretical	  application	  here	  is	  that	  heart	  rate,	  a	  much	  easier	  measure	  than	  cardiac	  
output,	  can	  determine	  in	  a	  patient	  the	  relative	  workload	  demands	  and	  how	  these	  are	  
fluctuating	  in	  the	  ICU	  patient.	  	  
Note,	  heart	  rate	  cannot	  compensate	  for	  factors	  that	  affect	  stroke	  volume,	  such	  as	  
poor	  venous	  return	  (Frank-­‐Starling	  mechanism)	  or	  contractility	  and	  function.	  However,	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heart	  rate	  can	  affect	  ejection	  fraction	  measurements	  because	  as	  heart	  rate	  increases	  in	  
the	  setting	  of	  cardiac	  muscle	  dysfunction,	  end	  diastolic	  volumes	  will	  appear	  to	  be	  lower	  
although	  there	  is	  no	  change	  in	  contractility.	  	  (95)	  
Physiologically,	  heart	  rate	  itself	  is	  regulated	  by	  hypothalamic	  and	  medullary	  
centers	  which	  increase	  sympathetic	  output,	  vagal	  input,	  baroreceptors	  which	  respond	  
to	  changes	  in	  peripheral	  resistance,	  and	  from	  afferent	  fibers	  that	  carry	  metabolic	  
signals	  from	  peripheral	  tissues.	  	  (95)	  Interestingly,	  heart	  rate	  does	  not	  appear	  to	  
respond	  well	  to	  isolated	  hypovolemia,	  as	  studied	  in	  healthy	  volunteers	  where	  20%	  of	  
blood	  volume	  was	  removed.	  	  (97)	  In	  this	  study,	  the	  patients	  did	  not	  respond	  with	  
reflexive	  tachycardia.	  Therefore,	  most	  likely,	  tachycardia	  that	  seen	  alongside	  
hypovolemia	  is	  a	  response	  that	  occurs	  primarily	  due	  heightened	  sensitivity	  to	  pain,	  
anxiety,	  or	  inflammatory	  process	  that	  is	  associated	  with	  the	  underlying	  cause	  of	  the	  
patient’s	  hypovolemia.	  	  
Numerous	  causes	  of	  tachycardia	  exist:	  the	  main	  differential	  being	  arrhythmias	  
versus	  sinus	  tachycardia.	  	  Arrhythmias	  like	  supraventricular	  tachycardia	  (atrial	  
fibrillation	  or	  junctional	  tachycardia)	  and	  ventricular	  tachycardias	  are	  more	  likely	  to	  be	  
suggestive	  of	  poorer	  outcomes.	  Sinus	  tachycardias	  involve	  feedback	  mechanisms	  that	  
will	  results	  from	  an	  affected	  blood	  pressure.	  This	  is	  known	  as	  reflex	  tachycardia	  and	  
occurs	  in	  response	  to	  hypotension,	  especially	  in	  distributive	  shock	  or	  severe	  
hypovolemia.	  This	  hypotension	  produces	  a	  sympathetic	  response	  where	  there	  is	  a	  
simultaneous	  increase	  in	  blood	  pressure	  and	  heart	  rate.	  	  In	  the	  operating	  room,	  many	  of	  
the	  anesthetic	  agents	  may	  induce	  tachycardia.	  Other	  causes	  to	  consider	  include	  
physiologic	  response	  such	  as	  exercise,	  stress,	  fear,	  anxiety	  OR	  drug	  induced,	  namely	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from	  beta	  adrenergic	  stimulation	  with	  isoproterenol,	  epinephrine,	  dobutamine	  or	  
anticholinergic	  medications,	  usually	  atropine.	  	  
The	  major	  causes	  of	  hypotension	  include	  hypovolemia	  (due	  to	  increased	  diuresis,	  
insensible	  loss	  poor	  intake,	  etc.),	  cardiogenic	  shock	  and	  distributive	  etiology	  (sepsis,	  
neurogenic,	  anaphylactic).	  Except	  for	  neurogenic	  and	  possibly	  cardiogenic	  (depending	  
on	  the	  exact	  mechanism)	  shock,	  the	  other	  conditions	  result	  in	  reflex	  tachycardia	  as	  the	  
body	  attempts	  to	  compensate	  to	  maintain	  perfusion.	  Hypotension	  can	  also	  be	  induced	  
by	  several	  of	  the	  anesthetic	  agents	  including	  the	  sedation	  gases	  and	  Propofol,	  
commonly	  used	  at	  induction.	  	  
VII.	  Goals	  of	  our	  study	  
Given	  the	  dearth	  of	  literature,	  our	  study	  presents	  an	  excellent	  opportunity	  to	  
look	  more	  closely	  at	  how	  short-­‐term	  variations	  and	  swings	  in	  blood	  pressure	  might	  play	  
a	  role	  in	  assessing	  a	  patient’s	  severity	  of	  illness	  and	  prognosis.	  	  	  
As	  aforementioned,	  we	  are	  designing	  a	  study	  with	  the	  hope	  and	  intent	  of	  
improving	  upon	  the	  current	  surgical	  APGAR	  score,	  which	  only	  measures	  static	  heart	  
rate	  and	  blood	  pressure.	  As	  such	  we	  are	  pursuing	  a	  pilot	  study	  gathering	  retrospective	  
data	  on	  post-­‐op	  SICU	  patient	  to	  see	  if	  incorporating	  physiologic	  variability	  will	  be	  at	  
least	  as	  good	  in	  discrimination	  and	  calibration	  to	  the	  current	  scale,	  the	  surgical	  APGAR	  
score.	  
Heart	  rate	  is	  the	  body’s	  ability	  to	  maintain	  cardiac	  output	  and	  perfusion	  in	  
the	  event	  of	  low	  stroke	  volume.	  Thus,	  fluctuations	  of	  the	  heart	  rate	  reflect	  the	  body	  
being	  in	  disequilibrium	  with	  swings	  of	  workloads	  and	  oxygen	  consumption	  over	  a	  
short	  period	  of	  time.	  This	  disequilibrium	  may	  be	  due	  to	  stressors,	  cardiac	  problems,	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autonomic	  instability.	  Whether	  exogenous	  or	  endogenous	  causes,	  in	  order	  to	  keep	  
up	  with	  this	  hemodynamic	  instability,	  the	  heart	  rate	  fluctuates	  to	  maintain	  cardiac	  
output	  which	  is	  what	  we	  expect	  to	  find	  in	  sicker	  patients.	  
In	  the	  APGAR	  studies,	  several	  different	  variables	  were	  analyzed	  in	  the	  initial	  
study	  but	  only	  heart	  rate,	  blood	  pressure	  and	  estimated	  blood	  loss	  intra-­‐operatively	  
were	  considered	  relevant.	  	  Therefore,	  we	  felt	  that	  it	  would	  be	  best	  to	  focus	  on	  these	  
variables	  in	  our	  study	  rather	  than	  reinvent	  the	  wheel	  and	  look	  at	  all	  the	  other	  variables	  
again.	  Our	  hope	  and	  goal	  is	  to	  maintain	  simplicity	  while	  providing	  some	  improvement	  
on	  current	  scores.	  	  
Our	  group	  has	  previously	  published	  an	  abstract	  looking	  closely	  at	  variation	  in	  
intraoperative	  heart	  rate	  and	  blood	  pressure.	  Ten	  colectomy	  and	  vascular	  surgeries	  
cases	  were	  randomly	  selected	  and	  intraoperative	  physiologic	  data	  was	  collected	  for	  
each.	  Variation	  in	  the	  data	  was	  analyzed	  and	  the	  results	  were	  converted	  to	  a	  simple,	  
user-­‐friendly	  scale,	  which	  was	  subsequently	  compared	  to	  the	  APGAR	  score.	  	  The	  
abstract	  clearly	  demonstrates	  that	  the	  APGAR	  score	  and	  our	  proposed	  scale	  are	  very	  
different	  in	  terms	  of	  the	  underlying	  premise	  and	  the	  data	  collected.	  Given	  that	  we	  have	  
this	  technique	  and	  have	  developed	  this	  scale	  for	  intra-­‐operative	  studies,	  we	  hope	  to	  
apply	  this	  to	  our	  post-­‐operative,	  ICU	  data.	  We	  believe	  that	  this	  emphasis	  on	  the	  
patient’s	  hemodynamic	  status	  and	  lability	  will	  yield	  a	  different	  point	  of	  reference	  and	  
invaluable	  information	  about	  that	  patient’s	  stability	  and	  prognosis.	  
Ideally,	  our	  study	  would	  like	  to	  compare	  this	  new	  scoring	  system	  with	  actual	  
outcomes	  however	  given	  that	  this	  is	  a	  preliminary	  study	  with	  just	  10	  patients,	  we	  
wanted	  to	  compare	  to	  a	  more	  standardized	  measure	  of	  outcome.	  Thus	  we	  focused	  on	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comparing	  our	  new	  scale	  to	  those	  well-­‐studied	  markers	  of	  patient	  outcomes,	  i.e.	  the	  
severity	  of	  illness	  scales	  such	  as	  APACHE	  II,	  MPM,	  and	  SAPS	  II.	  	  
	  
STATEMENT	  OF	  PURPOSE	  
Our	  purpose	  in	  this	  study	  is	  to	  study	  heart	  rate	  and	  blood	  pressure	  variation	  in	  
10	  post-­‐operative	  patients	  in	  the	  ICU	  and	  correlate	  this	  variation	  to	  current	  prognostic	  
scores,	  using	  the	  APGAR	  are	  the	  current	  standard	  and	  the	  severity	  of	  illness	  scores	  as	  
proxy	  markers	  of	  outcomes.	  	  
	  
METHODS	  	  
All	  patients	  used	  for	  this	  study	  were	  in	  the	  Surgical	  Intensive	  Care	  Unit	  at	  Yale	  
New	  Haven	  Hospital	  from	  October	  20-­‐Dec	  31,	  2011.	  	  HIC	  approval	  was	  obtained	  to	  
collect	  de-­‐identified	  data	  during	  the	  length	  of	  stay	  in	  the	  ICU.	  Patients	  were	  candidates	  
for	  this	  study	  if	  they	  had	  undergone	  any	  general	  surgical,	  vascular,	  ENT,	  transplant,	  or	  
orthopedic	  procedure	  leading	  to	  admission	  to	  the	  SICU.	  Most	  cases	  were	  elective.	  The	  
main	  inclusion	  criterion	  was	  that	  the	  patient	  should	  have	  had	  an	  arterial	  line	  placed	  in	  
the	  operating	  room	  so	  that	  we	  could	  get	  real-­‐time	  blood	  pressure	  readings	  at	  frequent	  
(5	  min)	  intervals.	  	  
Data	  were	  obtained	  for	  each	  patient	  from	  admission	  until	  as	  close	  to	  discharge	  
from	  the	  ICU	  as	  feasible	  or	  until	  the	  arterial	  line	  was	  discontinued.	  Data	  were	  printed	  to	  
reflect	  readings	  for	  every	  5	  minutes	  during	  this	  time	  period.	  The	  variables	  included	  
were	  heart	  rate,	  blood	  pressure,	  O2	  saturation,	  and	  respiratory	  rate.	  	  ST	  segments	  were	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collected	  on	  a	  few	  patients.	  	  The	  data	  could	  only	  be	  printed	  from	  the	  ICU	  monitors	  and	  
not	  electronically	  saved.	  	  I	  was	  designated	  to	  print	  these	  data.	  Along	  with	  the	  help	  of	  
multiple	  research	  assistants	  in	  the	  Anesthesiology	  Department,	  I	  then	  manually	  input	  
these	  data	  into	  an	  excel	  file	  for	  manipulation	  and	  data	  analysis.	  The	  data	  was	  
subsequently	  sent	  to	  our	  biostatistician	  who	  calculated	  measures	  of	  variation	  of	  the	  
data	  and	  the	  measures	  of	  variation	  that	  we	  chose	  were	  range,	  interquartile	  range,	  and	  
coefficient	  of	  variation.	  
The	  outcome	  measured	  was	  severity	  of	  illness	  scores	  as	  a	  proxy	  of	  measuring	  
mortality	  outcomes.	  Severity	  and	  illness	  scores	  were	  calculated	  by	  going	  through	  the	  
electronic	  medical	  record	  and	  obtaining	  the	  relevant	  laboratory	  and	  vital	  signs	  data.	  
These	  values	  were	  plugged	  into	  online	  calculators	  to	  calculate	  the	  scores.	  APGAR	  scores	  
were	  calculated	  by	  electronically	  downloading	  the	  operating	  room	  anesthesia	  record	  
and	  subsequently	  using	  the	  minimum	  heart	  rate	  and	  mean	  arterial	  pressure	  for	  the	  
score.	  Additionally,	  the	  estimated	  blood	  loss	  (EBL),	  also	  a	  component	  of	  the	  APGAR	  
score	  calculation,	  was	  found	  by	  looking	  into	  the	  surgical	  operative	  note	  in	  the	  patient’s	  
electronic	  chart.	  	  
The	  scores	  studied	  were	  the	  APACHE	  II,	  MPM2	  at	  admission	  and	  at	  24	  hours,	  
SAPS	  2,	  and	  SOFA.	  The	  APGAR	  scores	  were	  correlated	  to	  these	  scores	  as	  were	  measures	  
of	  variation	  for	  heart	  rate,	  systolic	  blood	  pressure	  and	  diastolic	  blood	  pressure	  data	  
from	  the	  ICU.	  For	  additional	  analysis,	  we	  also	  correlated	  the	  minimum,	  25%	  quartile,	  
median,	  75%	  quartile,	  and	  maximum	  values.	  	  




DIASTOLIC	  BLOOD	  PRESSURE	   Sample	  Correlation	   P	  value	  
ArtDBP	  Range-­‐	  APACHE	  II	   0.42683	   0.2276	  
ArtDBP	  Range	  -­‐	  SAPS2	   	   0.37657	   0.3320	  
ArtDBP	  Range	  -­‐	  MPM2	  24	  hr	   -­‐0.28338	   0.6767	  
ArtDBP	  Range	  -­‐	  SOFA	   0.24316	   0.5115	  
ArtDBP	  Range	  –	  APGAR(intraop)	   0.27867	   0.4489	  
ArtDBP	  Interquartile	  range-­‐	  APACHE	  II	   -­‐0.14154	   0.7062	  
ArtDBP	  Interquartile	  Range	  -­‐	  SAPS2	   0.27615	   0.4874	  
ArtDBP	  Interquartile	  Range	  -­‐	  MPM2	  24	  hr	   -­‐0.44801	   0.2020	  
ArtDBP	  Interquartile	  Range	  -­‐	  SOFA	   0	   1	  
ArtDBP	  Interquartile	  Range	  -­‐	  APGAR(intraop)	   0.40001	   0.2623	  
ArtDBP	  CV*-­‐	  APACHE	  II	   0.43769	   0.2143	  
ArtDBP	  CV	  -­‐	  SAPS2	   0.55000	   0.1298	  
ArtDBP	  CV	  -­‐	  MPM2	  24	  hr	   -­‐0.36775	   0.3074	  
ArtDBP	  CV	  -­‐	  SOFA	   0.21335	   0.5665	  
ArtDBP	  CV	  -­‐	  APGAR(intraop)	   0.69765	   0.0225	  
	  
Table	  2.	  Correlation	  of	  arterial	  Diastolic	  Blood	  Pressure	  measures	  of	  variation	  with	  the	  
APGAR	  score	  and	  severity	  of	  illness	  scores.	  	  
*CV	  is	  the	  coefficient	  of	  variation.	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No	  strong	  correlations	  were	  noted	  with	  the	  measures	  of	  variation	  to	  the	  arterial	  
diastolic	  blood	  pressure.	  The	  strongest	  correlation	  was	  the	  coefficient	  of	  variation	  with	  
the	  APGAR	  score	  (r2=0.69765,	  p=0.0225)	  which	  is	  not	  surprising	  given	  that	  a	  large	  
component	  of	  the	  APGAR	  score	  is	  calculated	  by	  using	  the	  mean	  arterial	  pressure	  (MAP).	  
SYSTOLIC	  BLOOD	  PRESSURE	   Sample	  Correlation	   P	  value	  
ArtSBP	  Range-­‐	  APACHE	  II	   0.47417	   0.2276	  
ArtSBP	  Range	  -­‐	  SAPS2	   0.73333	   0.3320	  
ArtsBP	  Range	  -­‐	  MPM2	  24	  hr	   0.24309	   0.6767	  
ArtSBP	  Range	  -­‐	  SOFA	   0.25860	   0.5115	  
ArtSBP	  Range	  -­‐	  APGAR(intraop)	   0.09261	   0.4489	  
ArtSBP	  Interquartile	  range-­‐	  APACHE	  II	   0.10976	   0.7706	  
ArtSBP	  Interquartile	  Range	  -­‐	  SAPS2	   0.41841	   0.2749	  
ArtSBP	  Interquartile	  Range	  -­‐	  MPM2	  24	  hr	   0.08753	   0.6171	  
ArtSBP	  Interquartile	  Range	  -­‐	  SOFA	   0.05836	   0.8771	  
ArtSBP	  Interquartile	  Range	  -­‐	  APGAR(intraop)	   0.00310	   0.9935	  
ArtSBP	  CV-­‐	  APACHE	  II	   0.41945	   0.2369	  
ArtSBP	  CV	  -­‐	  SAPS2	   0.43333	   0.2557	  
ArtSBP	  CV	  -­‐	  MPM2	  24	  hr	   0.20569	   0.5809	  
ArtSBP	  CV	  -­‐	  SOFA	   0.14870	   0.6918	  
ArtSBP	  CV	  -­‐	  APGAR(intraop)	   0.00617	   0.9870	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Table	  3.	  Correlation	  of	  arterial	  Systolic	  Blood	  Pressure	  measures	  of	  variation	  with	  the	  
APGAR	  score	  and	  severity	  of	  illness	  scores.	  
No	  strong	  correlations	  were	  noted	  with	  the	  measures	  of	  variation	  to	  the	  arterial	  
systolic	  blood	  pressure.	  The	  strongest	  correlation	  was	  the	  range	  with	  the	  SAPS2	  score	  	  
(r2=0.73333,	  p=0.3320)	  but	  the	  correlation	  not	  statistically	  significant.	  
HEART	  RATE	   Sample	  Correlation	   P	  value	  
HR	  Range-­‐	  APACHE	  II	   -­‐0.00610	   0.1727	  
HR	  Range	  -­‐	  SAPS2	   0.34310	   0.0219	  
HR	  Range	  -­‐	  MPM2	  24	  hr	   -­‐0.32823	   0.5116	  
HR	  Range	  -­‐	  SOFA	   0.07133	   0.4839	  
HR	  Range	  -­‐	  APGAR(intraop)	   0.72455	   0.8059	  
HR	  Interquartile	  range-­‐	  APACHE	  II	   -­‐0.31783	   0.3837	  
HR	  Interquartile	  Range	  -­‐	  SAPS2	   0.53629	   0.1424	  
HR	  Interquartile	  Range	  -­‐	  MPM2	  24	  hr	   0.42173	   0.2340	  
HR	  Interquartile	  Range	  -­‐	  SOFA	   0.18558	   0.6194	  
HR	  Interquartile	  Range	  -­‐	  APGAR(intraop)	   -­‐0.14557	   0.6981	  
HR	  CV-­‐	  APACHE	  II	   0.34651	   0.3389	  
HR	  CV	  -­‐	  SAPS2	   0.56667	   0.1155	  
HR	  CV	  -­‐	  MPM2	  24	  hr	   -­‐0.11219	   0.7656	  
HR	  CV	  -­‐	  SOFA	   0.07112	   0.8505	  
HR	  CV	  -­‐	  APGAR(intraop)	   0.54948	   0.1022	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Table	  4.	  Correlation	  of	  heart	  rate	  measures	  of	  variation	  with	  the	  APGAR	  score	  and	  
severity	  of	  illness	  scores.	  
	  
The	  range	  of	  heart	  rate	  did	  correlate	  well	  with	  the	  APGAR	  score	  but	  not	  to	  any	  
statistical	  significance	  (r2=0.72455,	  p=0.8059).	  
	  
	   Sample	  Correlation	   P	  value	  
APACHE	  II-­‐APGAR(intraop)	   -­‐0.00929	   0.9804	  
APACHE	  II-­‐MPM2	  24	  hr	   0.44389	   0.2069	  
APACHE	  II-­‐SAPS2	   0.85356	   0.0019	  
APACHE	  II-­‐SOFA	   0.55120	   0.1009	  
APGAR(intraop)-­‐MPM2	  24	  hr	   -­‐0.70162	   0.0213	  
APGAR(intraop)-­‐SAPS2	   0.11815	   0.7712	  
APGAR(intraop)-­‐SOFA	   -­‐0.06915	   0.8546	  
MPM2-­‐24hr	  –	  SAPS2	   0.42749	   0.2631	  
MPM2-­‐24hr	  -­‐	  SOFA	   0.33910	   0.3502	  
SAPS2-­‐SOFA	   0.44333	   0.2433	  
	  
Table	  5.	  Correlation	  of	  each	  severity	  of	  illness	  score	  to	  the	  other	  scores	  
	  
The	  strong	  correlations	  were	  noted	  here.	  An	  inverse	  relationship	  between	  
APGAR	  and	  MPM	  at	  24	  hours	  (r2	  =	  -­‐0.70162,	  p	  =	  0.0213)	  was	  found	  to	  be	  is	  statistically	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significant.	  APACHE	  II	  and	  SAPS2	  were	  also	  found	  to	  be	  well	  correlated	  and	  the	  
relationship	  was	  statistically	  significant	  (r2	  =	  0.85356,	  p	  =	  0.0019).	  
	  
DISCUSSION	  
The	  APGAR	  score,	  which	  is	  advantageous	  in	  many	  ways	  as	  describe	  above,	  we	  
believe	  is	  not	  the	  best	  possible	  measure	  for	  cardiovascular	  instability	  in	  the	  operative	  
room	  or	  post-­‐operative	  setting.	  	  Moreover,	  the	  severity	  of	  illness	  indices	  do	  not	  weigh	  
hemodynamic	  parameters	  heavily	  into	  their	  calculations.	  Our	  group,	  however,	  feels	  that	  
cardiovascular	  status	  is	  an	  important	  consideration	  in	  post-­‐operative	  course	  and	  a	  
major	  cause	  of	  mortality	  and	  possibly	  morbidity	  as	  well.	  We	  believe	  that	  a	  scoring	  
system	  developed	  exclusively	  from	  these	  parameters	  may	  be	  useful	  in	  determining	  
prognosis,	  resource	  allocation,	  and	  length	  of	  stay	  in	  the	  ICU.	  	  
As	  such,	  this	  preliminary	  study	  closely	  analyzed	  the	  measures	  of	  heart	  rate,	  
systolic	  blood	  pressure,	  and	  diastolic	  blood	  pressure	  variation	  in	  the	  post-­‐operative	  
setting	  in	  the	  intensive	  care	  unit.	  	  We	  however	  did	  not	  find	  any	  correlation	  with	  our	  
proxy	  outcome	  measures	  of	  the	  severity	  of	  illness	  scores	  or	  the	  APGAR	  score.	  While	  
disappointing,	  it	  is	  not	  surprising.,	  As	  mentioned	  before,	  the	  other	  scores	  do	  not	  heavily	  
utilize	  these	  parameters	  and	  so	  our	  findings	  verify	  and	  confirm	  this.	  	  	  
We	  recognize	  that	  a	  major	  limitation	  to	  our	  study	  is	  that	  we	  had	  a	  very	  small	  
sample	  size.	  However,	  our	  goal	  was	  not	  to	  get	  a	  definitive	  answer	  but	  explore	  this	  as	  a	  
potential	  new	  index	  of	  cardiovascular	  variation	  that	  could	  possibly	  be	  applied	  to	  a	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larger	  cohort	  and/or	  database	  of	  patient	  information	  and	  outcomes	  to	  develop	  a	  new	  
scoring	  system	  and	  validate	  it.	  
Of	  note,	  we	  did	  not	  see	  any	  correlations	  of	  our	  cardiovascular	  data	  with	  the	  
established	  scoring	  systems	  but	  we	  also	  did	  not	  find	  any	  strong	  correlations	  between	  
the	  established	  scoring	  systems	  either.	  This	  finding	  was	  initially	  surprising	  but	  rather	  
logical	  given	  that	  the	  different	  scoring	  measures	  incorporate	  vastly	  different	  input	  
parameters	  and	  apply	  completely	  different	  weighting	  systems	  for	  those	  parameters	  in	  
an	  attempt	  to	  predict	  similar	  outcomes,	  i.e.	  provide	  the	  same	  output	  in	  their	  calculation,	  
for	  the	  studied	  patients.	  Moreover,	  each	  established	  scoring	  system	  was	  developed	  in	  
its	  own	  cohort,	  population	  study,	  as	  well	  as	  within	  a	  specific	  temporal	  frame.	  As	  
mentioned,	  geography	  and	  time	  can	  profoundly	  affect	  the	  calibration	  of	  the	  scoring	  
system	  and	  most	  likely	  these	  established	  scoring	  systems	  are	  not	  well	  calibrated	  for	  our	  
patient	  population	  in	  New	  Haven	  CT	  at	  the	  time	  the	  data	  was	  collected	  (2012).	  	  
Several	  limitations	  exist	  in	  this	  study.	  	  First	  off,	  we	  did	  not	  directly	  measure	  
outcomes	  and	  this	  is	  discussed	  above.	  Secondly,	  patients	  in	  the	  study	  were	  in	  the	  ICU	  
for	  different	  lengths	  of	  time	  and	  this	  was	  not	  controlled	  for	  or	  factored	  into	  the	  analysis.	  
Obviously,	  patients	  in	  the	  ICU	  for	  longer	  periods	  of	  time	  may	  have	  an	  increased	  
likelihood	  of	  outliers	  that	  may	  skew	  the	  data.	  Thirdly,	  in	  our	  preliminary	  analysis	  we	  
did	  not	  factor	  in	  night-­‐time	  dipping	  of	  blood	  pressures	  as	  normal	  variation	  in	  our	  
analysis	  of	  blood	  pressure	  lability.	  This	  is	  a	  major	  flaw	  and	  will	  have	  to	  be	  redressed	  in	  
further	  analysis.	  We	  also	  introduced	  a	  significant	  bias	  because	  we	  did	  not	  include	  all	  
ICU	  patients	  but	  instead	  took	  a	  sample	  of	  them	  for	  this	  study.	  Sampling	  of	  ICU	  patients	  
for	  prognostic	  scoring	  systems	  instead	  of	  including	  all	  patients	  has	  been	  shown	  to	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create	  skewed	  results	  (41).	  Finally,	  secondary	  endpoints	  cannot	  be	  valid	  if	  the	  primary	  
endpoint	  is	  not	  statistically	  significant.	  	  	  (98)	  The	  POISE	  PeriOperative	  Ischemic	  
Evaluation	  trial	  showed	  that	  surrogate	  endpoints	  do	  not	  accurately	  predict	  mortality	  
and	  therefore	  not	  recommended	  for	  studies	  in	  which	  the	  aim	  is	  to	  reduce	  mortality.	  	  
(99)	  We	  have	  attempted	  to	  use	  a	  surrogate	  endpoint	  to	  compare	  scores	  but	  cannot	  
make	  extrapolations	  or	  conclusions	  about	  the	  utility	  of	  our	  score	  in	  assessing	  other	  
outcomes	  such	  as	  morbidity,	  mortality,	  length	  of	  ICU	  stay,	  etc.	  Finally,	  we	  may	  have	  had	  
some	  bias	  and	  data	  entry	  errors	  as	  part	  of	  our	  study.	  Given	  that	  it	  was	  not	  feasible	  to	  
electronically	  capture	  the	  physiologic	  data	  from	  the	  monitors	  in	  the	  ICU,	  we	  had	  no	  
choice	  but	  to	  manually	  enter	  the	  data	  by	  hand	  into	  an	  excel	  sheet	  which	  may	  result	  in	  
potential	  data	  entry	  errors.	  	  
As	  mentioned	  earlier,	  this	  project	  is	  just	  a	  beginning,	  an	  initial	  investigation,	  into	  
the	  possibility	  of	  using	  hemodynamic	  parameters	  as	  a	  means	  to	  stratify	  patients.	  We	  
hope	  that	  cardiovascular	  status	  as	  measured	  by	  heart	  rate	  and	  blood	  pressure	  lability	  
will	  ultimately	  be	  useful	  in	  predicting	  prognosis	  for	  individual	  patients	  and	  thus	  stratify	  
which	  patients	  will	  ultimately	  require	  greater	  ICU	  resources.	   	  
The	  group	  has	  multiple	  ideas	  for	  future	  projects	  that	  can	  stem	  and	  branch	  out	  
from	  this	  initial	  study.	  	  One	  such	  idea	  is	  to	  go	  back	  to	  these	  charts	  and	  find	  out	  what	  
exactly	  the	  outcomes	  were	  for	  the	  10	  patients.	  If	  this	  is	  done,	  then	  we	  no	  longer	  need	  to	  
rely	  on	  the	  severity	  of	  illness	  scores	  as	  a	  proxy	  for	  the	  outcomes.	  A	  second	  idea	  is	  to	  
build	  off	  our	  previous	  abstract	  for	  intraoperative	  hemodynamic	  lability	  and	  apply	  the	  
scoring	  system	  that	  was	  developed	  in	  that	  abstract	  to	  assess	  patients	  in	  the	  ICU.	  We	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could	  then	  expand	  to	  a	  larger	  sample	  size	  to	  attempt	  to	  calibrate	  our	  scoring	  system	  
well	  and	  later	  validate	  it	  in	  a	  different	  population.	  	  	  
A	  third	  idea	  is	  to	  compare	  our	  scoring	  system	  the	  Therapeutic	  Intervention	  
Scoring	  System	  (TISS).	  	  (100)	  The	  TISS	  measures	  severity	  of	  illness	  based	  on	  type	  and	  
amount	  of	  treatment	  given	  to	  the	  patient	  and	  so	  is	  very	  useful	  in	  determining	  how	  many	  
resources	  a	  patient	  consumes.	  Using	  this	  scoring	  system,	  it	  can	  be	  determined	  whether	  
a	  patient	  can	  go	  to	  the	  floor,	  step	  down,	  or	  the	  ICU	  based	  on	  the	  level	  of	  nursing	  care	  the	  
patient	  would	  require.	  	  Elements	  incorporated	  into	  the	  scoring	  system	  (updated	  in	  
1983)	  include	  cardiac	  arrest	  in	  the	  last	  48	  hours,	  ventilation,	  arterial	  infusion,	  dialysis,	  
catheters/monitoring	  (pulmonary	  artery,	  intraarterial	  infusion,	  arterial	  line,	  chest	  
tubes),	  and	  a	  variety	  of	  emergency	  procedures.	  (101)	  This	  ICU	  index	  may	  provide	  a	  
more	  meaningful	  comparison	  for	  our	  scoring	  system	  since	  it	  is	  focused	  on	  acute	  events.	  
Our	  scoring	  system	  is	  more	  aligned	  to	  the	  purpose	  of	  determining	  how	  to	  stratify	  
individual	  patient	  prognosis	  and	  resource	  allocation	  and	  the	  TISS	  is	  more	  oriented	  to	  
this	  purpose	  than	  the	  APACHE	  II,	  SOFA,	  MPM2,	  SAPS2,	  and	  APGAR	  scores.	  
	  The	  fourth	  idea	  was	  to	  simply	  study	  the	  correlation	  between	  severity	  of	  illness	  
scores.	  Comparisons	  of	  the	  scores	  have	  been	  made	  in	  numerous	  studies	  with	  the	  
intention	  of	  determining	  which	  is	  the	  best	  prognostic	  score,	  best	  predictor	  of	  ICU	  length	  
of	  stay,	  and	  overall	  ICU	  performance.	  However,	  no	  study	  could	  be	  found	  via	  a	  Pubmed	  
search	  showing	  how	  the	  scores	  correlate	  with	  each	  other.	  We	  would	  like	  to	  find	  out	  
what	  the	  exact	  correlations	  are	  between	  the	  severity	  of	  illness	  indices	  by	  calculating	  
and	  correlating	  the	  scores	  for	  a	  large	  sample	  of	  ICU	  patients.	  This	  correlation	  would	  be	  
helpful,	  especially	  for	  small	  studies,	  like	  this	  one.	  The	  reason	  is	  that	  if	  the	  same	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correlation	  is	  found	  in	  the	  small	  study	  as	  is	  found	  in	  the	  large	  population,	  then	  one	  can	  
be	  relatively	  sure	  that	  in	  fact	  the	  power	  of	  the	  small	  study	  is	  quite	  good	  and	  results	  
more	  promising.	  	  
Yet	  another	  idea	  is	  to	  compare	  our	  score	  to	  the	  Rothman	  Index,	  which	  is	  
currently	  in	  use	  at	  Yale	  New	  Haven	  Hospital.	  This	  index	  is	  found	  on	  the	  nursing	  tab	  of	  
our	  electronic	  medical	  record	  and	  was	  introduced	  as	  recently	  as	  late-­‐fall	  of	  2011.	  With	  
further	  investigation,	  it	  can	  be	  determined	  if	  this	  score	  has	  been	  calibrated	  
geographically,	  i.e.	  specifically	  for	  the	  patients	  seen	  within	  Connecticut	  or	  within	  the	  
Yale	  New	  Haven	  Hospital	  System.	  If	  this	  is	  true,	  then	  we	  can	  compare	  our	  
hemodynamic-­‐based	  score	  to	  the	  Rothman	  Index	  to	  assess	  what	  sort	  of	  information	  
each	  provides	  and	  what	  the	  best	  applications	  for	  each	  would	  be,	  if	  any.	  	  
Another	  question	  that	  arises	  from	  this	  work	  is	  whether	  the	  interquartile	  range	  
correlates	  with	  the	  range.	  The	  range	  itself	  contains	  outliers	  as	  does	  the	  APGAR	  score,	  
whereas	  the	  interquartile	  range	  may	  be	  a	  better	  measure	  of	  real	  instability.	  If	  morbidity	  
outcomes	  could	  be	  measured,	  an	  interesting	  question	  would	  be	  whether	  the	  
interquartile	  range	  better	  correlates	  to	  outcomes	  vs.	  the	  range	  and/or	  the	  APGAR	  score.	  	  
Finally,	  as	  mentioned	  earlier,	  blood	  pressure	  is	  known	  to	  dip	  at	  night	  and	  this	  is	  
considered	  fairly	  normal.	  In	  the	  ICU,	  sleep	  patterns	  are	  disturbed	  and	  circadian	  rhythms	  
out	  of	  sync.	  An	  interesting	  question	  for	  future	  work	  would	  be	  to	  see	  if	  nighttime	  dipping	  
of	  blood	  pressures	  occurs	  in	  the	  ICU	  at	  all.	  	  	  
	  
	  
	   	  




Table	  6.	  PREOPERATIVE	  CHARACTERISTICS	  
	  
Pt	  1	  	   Pt	  2	  	   Pt	  3	  	   Pt	  4	  	   Pt	  5	  	   Pt	  6	   Pt	  7	  	   Pt	  8	  	   Pt	  9	  	   Pt	  10	  	  
	  
	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	  	  
age	   77	   74	   43	   57	   53	   57	   83	   59	   68	   71	  
female	   Y	   N	   Y	   Y	   N	   N	   Y	   Y	   Y	   Y	  
non	  caucasian	   no	   ?	  
	  
?	   ?	   ?	   no	   ?	   ?	   ?	  
BMI	  (>35	  vs	  <	  18.5)	   19.2	   26.9	   33.6	   24.7	   28.0	   25.0	   30.3	   32.9	   26.1	   25.6	  
Cardiovascular	  
disease	  	   no	   no	   no	   no	   no	   no	   yes	   no	   no	   no	  
pulm	  disease)	   no	   no	   yes	   no	   no	   no	   no	   no	   no	   no	  
DM	   No	   no	   no	   no	   yes	   no	   no	   no	   no	   no	  
preoperative	  sepsis	   No	   no	   no	   no	   no	   no	   no	   no	   no	   no	  
wound	  
contaminated	  or	  
dirty	   No	   no	   no	   no	   no	   no	   no	   no	   no	   no	  
procedure	  for	  
malignancy	   No	   yes	   no	   no	   yes	   no	   yes	   yes	   yes	   yes	  
bleeding	  
disorder/transfusion	  
>	  4	  U	  PRBC	  preop	   No	  
	  
no	   no	   no	   no	   no	   no	  
	  
no	  




procedure	   No	   no	   no	   yes	   no	   no	   no	   no	   no	   no	  
ASA	  class	  >=3	   Yes	   yes	   yes	   yes	   no	   yes	   yes	   no	   yes	   yes	  
HTN	   Yes	   yes	   no	   yes	   no	   no	   yes	   no	   yes	   yes	  
dyspnea	   No	   no	   no	   no	   no	   yes	   no	   no	   no	   no	  
renal	  failure	   No	   no	   no	   no	   no	   no	   no	   no	   no	   no	  
hx	  of	  stroke	  or	  TIA	   No	   no	   no	   no	   no	   no	   no	   no	   no	   no	  
current	  smoker	   No	   no	   no	   no	   yes	   yes	   no	   no	   no	   no	  
disseminated	  cancer	   No	   no	   no	   no	   no	   no	   yes	   no	   yes	   yes	  
weight	  loss	  >	  10%	  in	  
6	  months	   ?	   yes	   no	   no	   ?	   ?	   yes	   no	   yes	   ?	  
oral	  or	  parenteral	  
corticosteroid	  use	   No	   no	   yes	   no	   no	   no	   no	   no	   no	   no	  
ascites	   no	   no	   no	   yes	   no	   no	   no	   no	   no	   no	  
esophageal	  varices	   no	   no	   no	   no	   no	   no	   no	   no	   no	   no	  
rest	  pain	  or	  
gangrene	   no	   no	   no	   no	   no	   no	   no	   no	   no	   no	  
coma	   no	   no	   no	   yes	   no	   no	   no	   no	   no	   no	  
DNR	  status	   no	   no	   no	   no	   no	   no	   no	   yes	   yes	   no	  
	  
*cardiovascular	  disease:	  (MI,	  CHF,	  PVD,	  stroke,	  prior	  revascularization)	  
Pulm:	  (PNA,	  COPD,	  ventilator	  dependent	  











































APACHE	  2	   9	   30	   25	   13	   8	   13	   14	   16	   27	   18	   7	   11	   11	  
MPM2	  
admit	  	   3	   3	  
	  
1	   1	   1	   2	   2	   2	  
	  
3	   3	  
	  MPM	  	  
24	  hr	   2	   5	   3	   0	   0	   0	   1	   2	   2	   2	   1	   3	   0	  
SAPS2	  
	  
76	   59	   24	   13	   35	   18	   28	   44	   46	   12	   21	   21	  
SOFA	   1	   14	   12	   2	   2	   1	   2	   1	   3	   3	   1	   2	   0	  
	   	   	   	   	   	   	   	   	   	   	   	   	   	  APGAR	  	   	  	  	  3	   3	  
	  
9	   5	   6	   3	   4	   6	  
	  

















75	   dev/mean	  
Pt	  1	  	   31	   12	   0.071477595	  
Pt	  2	   26	   15	   0.092931121	  
Pt	  3	   37	   6	   0.087646547	  
Pt	  4	   22	   6	   0.05167474	  
Pt	  5	   49	   12	   0.14348662	  
Pt	  6	   21	   9	   0.055801647	  
Pt	  7	   20	   6	   0.053633026	  
Pt	  8	   55	   12	   0.113093198	  
Pt	  9	   32	   11	   0.091789625	  
Pt	  10	   21	   7	   0.04650648	  
	  




75	   dev/mean	  
Pt	  1	   	  	  	  	  	  74	   22.8	   0.106590442	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Pt	  2	   80	   22	   0.138370415	  
Pt	  3	   179	   21.2	   0.124940845	  
Pt	  4	   70	   27	   0.148722988	  
Pt	  5	   84	   14	   0.136169782	  
Pt	  6	  	   39	   12	   0.064906996	  
Pt	  7	  	   64	   22.05	   0.179590251	  
Pt	  8	   98	   18	   0.145854159	  
Pt	  9	   16	   4.5	   0.037878148	  
Pt10	   58	   13.5	   0.086114274	  
	  




75	   dev/mean	  
Pt	  1	   35	   10	   0.090968845	  
Pt	  2	   32	   7	   0.108374084	  
Pt	  3	   81	   10	   0.163213223	  
Pt	  4	   26	   10	   0.113161428	  
Pt	  5	   43	   14.5	   0.16103766	  
Pt	  6	  	   53	   6.75	   0.093563437	  
Pt	  7	  	   28	   5.75	   0.113586684	  
Pt	  8	   46	   8	   0.159668827	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Pt	  9	   27	   4.5	   0.08618326	  
Pt10	   32	   7.5	   0.095327599	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Figure	  1.	  Various	  measures	  of	  beat-­‐to-­‐beat	  variability	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Table	  11.	  Variables	  used	  to	  calculate	  each	  of	  the	  severity	  of	  illness	  score	  
SCORES	   VARIABLES	  
APACHE	  II	   Temperature,	  respiratory	  rate,	  serum	  bicarbonate	  or	  arterial	  pH,	  serum	  
potassium,	  hematocrit,	  age,	  mean	  arterial	  pressure,	  A-­‐a	  gradient	  if	  FiO2>	  
or	  =	  50%	  OR	  PaO2	  if	  FiO2<	  50%,	  serum	  creatinine,	  white	  blood	  cell	  count,	  
heart	  rate,	  serum	  sodium,	  Glasgow	  coma	  scale	  (GCS)	  score,	  chronic	  organ	  
insufficiency	  or	  immune-­‐compromised.	  
SAPS	  2	   Type	  of	  admission,	  age,	  temperature,	  BUN,	  Serum	  sodium,	  chronic	  
diseases,	  Systolic	  Blood	  pressure,	  PaO2/FiO2	  mmHg	  if	  mechanically	  
ventilated	  or	  CPAP,	  white	  blood	  cell	  count,	  serum	  bicarbonate,	  GCS	  score,	  
heart	  rate,	  urine	  output,	  serum	  potassium,	  bilirubin	  
MPM-­‐admit	  
II	  
Medical	  or	  unscheduled	  surgery	  admission,	  metastatic	  neoplasm,	  
cirrhosis,	  chronic	  renal	  insufficiency,	  CPR	  prior	  to	  admission,	  GCS	  score,	  
heart	  rate,	  systolic	  blood	  pressure,	  acute	  renal	  failure,	  cardiac	  
dysrhythmia,	  cerebrovascular	  incident,	  gastrointestinal	  bleeding,	  
intracranial	  mass	  effect,	  mechanical	  ventilation,	  age	  
MPM-­‐24	  hr	  
II	  
Medical	  or	  unscheduled	  surgery	  admission,	  metastatic	  neoplasm,	  
cirrhosis,	  creatinine	  >	  2.0,	  urine	  output,	  GCS	  score,	  confirmed	  infection,	  
intracranial	  mass	  effect,	  mechanical	  ventilation,	  vasoactive	  drugs	  >	  or	  =	  1	  
hour,	  paO2<	  60	  mmHg,	  Prothrombin	  time	  >	  standard+	  3	  sec,	  age	  
SOFA	   PaO2/FiO2,	  pressors,	  bilirubin,	  coagulation	  studies,	  GCS	  score,	  creatinine	  
OR	  urine	  output.	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